Skip to main content
SpringerLink
Log in

Hematopoietic Tissue I: Response Modification by Erythropoietin

  • Chapter
Modification of Radiation Response

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 142 Accesses

Abstract

Erythropoietin (EPO) has been identified as a 34-kDa glycoprotein hormone which controls red blood cell production. It is the only hematopoietic growth factor that is regulated by hypoxia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Antonadou A, Cadarmakis E, Sarris G, Tzigounis T (1998) Effect of the administration of recombinant human erythropoietin in patients with pelvic malignancies during radiotherapy. Radiother Oncol 48[Suppl 1]:S122

    Google Scholar 

  • Beck I, Weinmann R, Caro J (1993) Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 82:704–711

    PubMed  CAS  Google Scholar 

  • Becker A, Stadler P, Lavey R, Haensgen G, Kuhnt T, Lautenschlaeger C, Feldmann HJ, Molls M, Dunst J (2000) Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 46:459–466

    Article  PubMed  CAS  Google Scholar 

  • Beguin Y (2002) Predictive factors for response of anemia to recombinant human erythropoietin. In: Nowrousian MR (ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Google Scholar 

  • Berdel WE, Oberberg D, Reufi B, Thiel E (1991) Studies on the role of recombinant erythropoietin in the growth regulation of human non-hematopoietic cells in vitro. Ann Hematol 63:5–8

    Article  PubMed  CAS  Google Scholar 

  • Blanchard KL, Fandrey J, Goldberg MA (1993) Regulation of the erythropoietin gene. Stem Cells 11[Suppl 1]:1–7

    Article  PubMed  CAS  Google Scholar 

  • Blohmer JU, von Minckwitz G, Paepke S, Thomssen C, Kimmig R, Petry U, Würschmidt J, Pfisterer J, Lichtenegger W (2002) Sequential adjuvant chemo-radiotherapy with vs. without erythropoietin for patients with high-risk cervical cancer — second analysis of a prospective, randomized, open and controlled AGO-and NOGGO-intergroup study. Proc ASCO 21:206a

    Google Scholar 

  • Bunn HF, Poyton RO (1996) Oxygen sensing and molecular adaption to hypoxia. Physiol Rev 76:839–885

    PubMed  CAS  Google Scholar 

  • Bush RS (1986) The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 12:2047–2050

    Article  PubMed  CAS  Google Scholar 

  • Canaday DJ, Regine WF, Mohiuddin M, Zollinger W, Machtay M, Schultz D, Rudoltz MS (1999) Significance of pretreatment hemoglobin levels in patients with T1 glottic cancer. Radiat Oncol Invest 7:42–48

    Article  CAS  Google Scholar 

  • Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review. Cancer 91:2214–2221

    Article  PubMed  CAS  Google Scholar 

  • Cerami A (2001) Beyond erythropoiesis: novel applications for recombinant erythropoietin. Semin Hematol 38[Suppl 7]:33–39

    Article  PubMed  CAS  Google Scholar 

  • Cerami A, Brins M, Ghezzi P, Cerami C, Itri LM (2002) Neuroprotective properties of epoietin alfa. Nephrol Dial Transplant 17[Suppl 1]:8–12

    Article  PubMed  CAS  Google Scholar 

  • Demetri GD, Kris M, Wade J et al (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 16:3412–3425

    PubMed  CAS  Google Scholar 

  • Dunst J, Molls M (2002a) Incidence and impact of anemia in radiation oncology. In: Nowrousian MR (ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Google Scholar 

  • Dunst J, Molls M (2002b) Relationship between anemia and tumor hypoxia. In: Nowrousian MR (ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Google Scholar 

  • Dusenbery KE, McGuire WA, Holt PJ, Carson LF, Fowler JM, Twiggs LB, Potish RA (1994) Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 29:1079–1084

    Article  PubMed  CAS  Google Scholar 

  • Evans IC, Bergsjø P (1965) The influence of anemia on the results of radiotherapy in carcinoma of the cervix. Radiology 84:709–717

    PubMed  CAS  Google Scholar 

  • Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr, Coia LR (1995) Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 13: 2077–2083

    PubMed  CAS  Google Scholar 

  • Frommhold H, Guttenberger R, Henke M (1998) The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther Onkol 174 [SupplIV]:31–34

    PubMed  Google Scholar 

  • Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP (2000) Anemia, hypoxia and transfusion in patients with cervical cancer: a review. Radiother Oncol 57:13–19

    Article  PubMed  CAS  Google Scholar 

  • Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH (2001) Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19:2875–2882

    PubMed  CAS  Google Scholar 

  • Girinksi T, Pejovic-Lenfant MH, Bourhis J, Campana F, Cosset JM, Petit C, Malaise EP, Haie C, Gerbaulet A, Chassagne D (1989) Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 16: 37–42

    Article  Google Scholar 

  • Glaspy J, Bukowski R, Steinberg D et al (1997) Impact of therapy with epoietin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 15:1218–1234

    PubMed  CAS  Google Scholar 

  • Glimelius B, Linne T, Hoffman K et al (1998) Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. J Clin Oncol 16:434–440

    PubMed  CAS  Google Scholar 

  • Grau C, Overgaard J (1998) Significance of hemoglobin concentrations for treatment outcome. In: Molls M, Vaupel P (eds) Blood perfusion and microenvironment of human tumors. Implications for clinical radiooncology. Springer, Berlin Heidelberg New York, pp 101–112

    Chapter  Google Scholar 

  • Grogan M, Thomas GM, Melamed I, Wong FL (1999) The importance of maintaining high hemoglobin levels during radiation treatment of carcinoma of the cervix. Cancer 86: 1531–1536

    Article  Google Scholar 

  • Hannisdal E, Fossa SD, Host H (1993) Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy. Radiother Oncol 27:117–122

    Article  PubMed  CAS  Google Scholar 

  • Harrison L, Shasha D, Shiaova L, White C, Ramdeen B, Portenoy R (2001) Prevalence of anemia in cancer patients undergoing radiation therapy. Sem Oncol 28[Suppl 8]:54–59

    Article  CAS  Google Scholar 

  • Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin’s disease: International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 339: 1506–1514

    Article  PubMed  CAS  Google Scholar 

  • Henke M (2002) Clinical trials using rhEPO in radiation oncology. In: Nowrousian MR (ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Google Scholar 

  • Henke M, Guttenberger R, Barke A, Pajonk F, Pötter R, Frommhold H (1999) Erythropoietin for patients undergoing radiotherapy: a pilot study. Radiother Oncol 50:185–190

    Article  PubMed  CAS  Google Scholar 

  • Jelkmann W (2002) Pharmacology, pharmacokinetics and safety of rhEPO. In: Nowrousian MR (ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Google Scholar 

  • Kapp DS, Fisher D, Gutierrez E, Kohorn IE, Schwartz PE (1983) Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariate analysis of the effect of age, stage, histology, and blood counts on survival. Int J Radiat Oncol Biol Phys 9:445–455

    Article  PubMed  CAS  Google Scholar 

  • Kelleher DK, Matthiensen U, Thews O, Vaupel P (1995) Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol 34:379–384

    Article  PubMed  CAS  Google Scholar 

  • Kelleher DK, Matthiensen U, Thews O, Vaupel P (1996) Blood flow, oxygenation and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res 56:4728–4734

    PubMed  CAS  Google Scholar 

  • Lacombe C, Mayeux P (2002) Biology of erythropoietin. In: Nowrousian MR(ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Google Scholar 

  • Lavey RS, Dempsey WH (1993) Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 27:1147–1152

    Article  PubMed  CAS  Google Scholar 

  • Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, Coia L, Rotman M, Ortiz H (1998) Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 42:1069–1075

    Article  PubMed  CAS  Google Scholar 

  • Littlewood TJ (2002) Effect of rhEPO on survival in anemic cancer patients. In: Nowrousian MR (ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Google Scholar 

  • Littlewood TJ, Bajetta E, Nortier JW et al (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19:2865–2874

    PubMed  CAS  Google Scholar 

  • Logsdon MD, Eifel PJ (1999) FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43:763–775

    Article  PubMed  CAS  Google Scholar 

  • Ludwig H, Fritz E, Leitgeb C, Pecherstorfer M, Samonigg L, Schuster J (1994) Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 84: 1056–1063

    PubMed  CAS  Google Scholar 

  • MacDougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J, Egrie J (1999) Pharmacokinetics of novel erythropoiesis stimulating protein compared to epoietin alfa in dialysis patients. J Am Soc Nephrol 10:2392–2395

    PubMed  CAS  Google Scholar 

  • Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL (1990) Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689–1692

    Article  PubMed  CAS  Google Scholar 

  • Müller-Klieser W, Vaupel P, Manz R, Schmidseder R (1981) Intracapillary oxyhemoglobin saturation in malignant tumors in humans. Int J Radiat Oncol Biol Phys 7: 1397–1404

    Article  Google Scholar 

  • Nowrousian MR (2002) Pathophysiology of cancer-related anemia. In: Nowrousian MR (ed) Recombinant human erythropoietin (rhEPO) in clinical oncology. Springer, Vienna New York

    Chapter  Google Scholar 

  • Osterborg A, Brandberg Y, Molostova V et al (2002) Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies. J Clin Oncol 20:2486–2494

    Article  PubMed  CAS  Google Scholar 

  • Overgaard J (1988) The influence of hemoglobin concentrations on the response to radiotherapy. Scand J Clin Lab Invest 48:49–53

    Google Scholar 

  • Rosti V, Pedrazzoli P, Ponchio L, Zibera C, Novella A, Lucotti C, Robustelli della Cunna G, Cazzola M (1993) Effect of recombinant human erythropoietin on the hematopoietic and nonhematopoietic malignant cell growth in vitro. Haematologica 78:208–212

    PubMed  CAS  Google Scholar 

  • Rudat V, Dietz A, Schramm O, Conradt C, Maier H, Flentje M, Wannenmacher M (1999) Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 53:119–125

    Article  PubMed  CAS  Google Scholar 

  • Selzer E, Wachek V, Kodym R, Schlagbauer-Wadl H, Schlegel W, Pehamberger H, Jansen B (2000) Erythropoietin receptor expression in human melanoma cells. Melanoma Res 10:421–426

    Article  PubMed  CAS  Google Scholar 

  • Stüben G, Thews O, Poettgen C, Knuhmann K, Vaupel P, Stuschke M (2001) Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol 127:346–350

    Article  PubMed  Google Scholar 

  • Sweeney PJ, Nicolae D, Ignacio L, Chen L, Roach M, Wara W, Marcus KC, Vijayakumar S (1998) Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled phase II trial. Br J Cancer 77: 1996–2002

    Article  PubMed  CAS  Google Scholar 

  • Tarnawski R, Skladowski K, Maciejewski B (1997) Prognostic value of hemoglobin concentration in radiotherapy for cancer of the supraglottic larynx. Int J Radiat Oncol Biol Phys 38:1007–1011

    Article  PubMed  CAS  Google Scholar 

  • Thews O, König R, Kelleher DK, Kutzner J, Vaupel P (1998) Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 78:752–766

    Article  PubMed  CAS  Google Scholar 

  • Thews O, Kelleher DK, Vaupel P (2001) Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res 61:1358–1361

    PubMed  CAS  Google Scholar 

  • Van Acht MJ, Hermans J, Boks DE, Leer JW (1992) The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 23:229–235

    Article  PubMed  Google Scholar 

  • Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic environment of human tumors: a review. Cancer Res 49:6449–6465

    PubMed  CAS  Google Scholar 

  • Vaupel P, Thews O, Mayer A, Höckel S, Höckel M (2002) Oxygenation status of gynecological tumors: what is the optimal hemoglobin level? Strahlenther Onkol (in press)

    Google Scholar 

  • Wagner W, Hermann R, Hartlapp J, Esser E, Christoph B, Müller M, Krech R, Koch O (2000) Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther Onkol 176:73–80

    Article  PubMed  CAS  Google Scholar 

  • Westenfelder C, Baranowski RL (2000) Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 58:647–657

    Article  PubMed  CAS  Google Scholar 

  • Westphal G, Niederberger L, Blum C, Wollman Y, Knoch TA, Rebel W, Debus J, Friedrich E (2002) Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality. Tumori 88:150–159

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiotherapy, Martin-Luther-University Halle-Wittenberg, Dryanderstrasse 4, 06097, Halle, Germany

    J. Dunst MD (Professor)

Authors
  1. J. Dunst MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße 22, 81675, München, Germany

    Carsten Nieder MD

  2. Department of Experimental Radiation Oncology, UT MD Anderson Cancer Center, 1515 Holcombe Blvd., P.O. Box 66, Houston, TX, 77030, USA

    Luka Milas MD, PhD

  3. Department of Radiation Oncology, UT MD Anderson Cancer Center, 1515 Holcombe Blvd., P.O. Box 66, Houston, TX, 77030, USA

    K. Kian Ang MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dunst, J. (2003). Hematopoietic Tissue I: Response Modification by Erythropoietin. In: Nieder, C., Milas, L., Ang, K.K. (eds) Modification of Radiation Response. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55613-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55613-5_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62670-8

  • Online ISBN: 978-3-642-55613-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation